Skip to main
HSIC

Henry Schein (HSIC) Stock Forecast & Price Target

Henry Schein (HSIC) Analyst Ratings

Based on 14 analyst ratings
Buy
Strong Buy 14%
Buy 43%
Hold 36%
Sell 7%
Strong Sell 0%

Bulls say

Henry Schein is benefiting from a credible operational turnaround under new leadership, with the BOLD+1 plan targeting about $200M of annual cost reductions, roughly $125M of annual operating income improvement by exiting 2026E, and a mix shift toward high-growth, high-margin businesses that already represent about 25% of revenue and 47% of adjusted operating income. Its fundamentals are also supported by improving demand, as 1Q:26 adjusted EBITDA margin expanded to 8.6% (+41 bps y/y), adjusted EBITDA rose 11.6% y/y, U.S. Dental local internal growth accelerated to 4.1% y/y, and cloud-based users increased 25% y/y, while the company’s leadership in Dental, broad product offering, and sticky software-led customer relationships reinforce share retention and cross-sell opportunities. The outlook remains constructive because Dental demand is resilient and Medical appears to have been temporarily soft in 1Q:26 due to a light flu season rather than structural weakness, leaving room for growth re-acceleration as cost actions flow through, margins improve, and the company continues consolidating operations and reducing SG&A.

Bears say

Henry Schein is facing a fundamentally pressured demand backdrop because dental care is still often the service consumers are most likely to forgo when costs rise, and the company’s core end markets are exposed to lower insurance coverage, reimbursement pressure, and policy-driven uncertainty that could reduce volumes and delay discretionary procedures. Its largest revenue engine, Global Distribution and Value-Added Services, depends on high-touch customer relationships, third-party suppliers, and smooth logistics, but in 2025 the top 10 suppliers accounted for about 24% of aggregate purchases while the single largest supplier represented about 4%, leaving the business exposed to disruptions that could impair sales, operations, and customer trust. The outlook is further weakened by technology and cybersecurity risk, especially after back-to-back attacks in October and November 2023 that affected over 160,000 individuals and disrupted manufacturing, distribution, and e-commerce systems, showing that any repeat incident could create meaningful financial and reputational damage.

Henry Schein (HSIC) has been analyzed by 14 analysts, with a consensus rating of Buy. 14% of analysts recommend a Strong Buy, 43% recommend Buy, 36% suggest Holding, 7% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Henry Schein and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Henry Schein (HSIC) Forecast

Analysts have given Henry Schein (HSIC) a Buy based on their latest research and market trends.

According to 14 analysts, Henry Schein (HSIC) has a Buy consensus rating as of Oct 4, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $92.50, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $92.50, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Henry Schein (HSIC)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.